Chi-Fu Jeffrey Yang, MD, is a thoracic surgeon in the Massachusetts General Hospital Division of Thoracic Surgery and faculty at Harvard Medical School.
Departments, Centers, & Programs:
Division of Thoracic Surgery
55 Fruit Street
Boston, MA 02114-2696
- MD, Harvard Medical School
- Residency, Duke University Medical Center
- Fellowship, Stanford University Hospital
American Board Certifications
- Surgery, American Board of Surgery
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Mayne NR, Elser H, Darling AJ, Raman V, Liou D, Colson YL, D’Amico TA, Yang CJ. Estimating the Impact of Extended Delay to Surgery for Stage I Non-Small-Cell Lung Cancer on Survival. Annals of Surgery 2021. 273(5): 850-857.
Mayne NR, Lin BK, Darling AJ, Raman V, Patel D, Liou D, D’Amico TA, Yang CJ. Stereotactic Body Radiotherapy versus Delayed Surgery for Early Stage Non-small-cell Lung Cancer. Annals of Surgery 2020. 272(6):925-929.
Yang CJ et al. A National Analysis of Long-term Survival Following Thoracoscopic versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. Annals of Surgery 2019. 269 (1):163-171.
Yang CJ et al. A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic vs Open Lobectomy for Clinical Stage II Non-small-cell Lung Cancer. Annals of Surgery 2019. 273(3):595-605.
Yang CJ et al. Long-term Survival After Surgery Compared with Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. Annals of Surgery 2018. 268(6):1105-1112.
Yang CJ et al. Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. Chest 2017. 152(6):1239-1250.
Yang CJ et al. Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology 2016, 34(10):1057-64.
- Patient Education
- May | 4 | 2021
The Lung Cancer Forum, supported by the Division of Thoracic Surgery at Massachusetts General Hospital, is an initiative that brings medical experts together with the shared goal of furthering education, conversation and coordinated action around the topic of lung cancer.
- Patient Education
- Nov | 30 | 2020
In recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.